Amgen: Q3 EPS up 15%

(CercleFinance.com) - On Thursday evening Amgen reported non-GAAP EPS that is up 15% at $4.
70 for Q3 2022, with an adjusted operating margin that improved 4.2% to 52.5%.

However, the healthcare group's total revenues slipped 1% to 6.7 billion dollars, as volume growth of 8% was largely offset by a 5% decline in net selling price and a 2% negative FX impact.

For the current full year, Amgen said that it has revised its guidance, now targeting EPS of $17.25 to $17.85 on a non-GAAP basis, along with total revenue of 26 to 26.3 billion dollars.


Copyright (c) 2022 CercleFinance.com. All rights reserved.